Greenwich LifeSciences (GLSI) Enterprise Value (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Enterprise Value of -$6.2 million for Q4 2025, down 62.28% on a QoQ basis from -$3.8 million in Q3 2025, and down 50.98% year-over-year from -$12.6 million in Q4 2024.
Greenwich LifeSciences (GLSI) Enterprise Value (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$6.2 million for Q4 2025.
- Quarterly Enterprise Value fell 50.98% year-over-year to -$6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.2 million (down 50.98% YoY) and the FY2025 annual result came in at -$6.2 million, down 50.98% from the prior year.
- Enterprise Value was -$6.2 million for Q4 2025 at Greenwich LifeSciences, down from -$3.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.7 million in Q1 2025 and bottomed at -$30.4 million in Q1 2021.
- A 5-year average of -$13.0 million and a median of -$10.0 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 365.15% — and 2025, when it surged 56.75%.
- Greenwich LifeSciences' Enterprise Value stood at -$27.2 million in 2021, then soared by 50.49% to -$13.5 million in 2022, then surged by 48.1% to -$7.0 million in 2023, then soared by 41.45% to -$4.1 million in 2024, then sank by 50.98% to -$6.2 million in 2025.
- Business Quant data shows GLSI's Enterprise Value at -$6.2 million in Q4 2025, -$3.8 million in Q3 2025, and -$3.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | -6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.18 Mn |
| Sep 30, 2025 | -3.81 Mn |
| Jun 30, 2025 | -3.13 Mn |
| Mar 31, 2025 | -2.75 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | -7.22 Mn |
| Mar 31, 2024 | -5.51 Mn |
| Dec 31, 2023 | -6.99 Mn |
| Sep 30, 2023 | -9.14 Mn |
| Jun 30, 2023 | -10.94 Mn |
| Mar 31, 2023 | -11.91 Mn |
| Dec 31, 2022 | -13.47 Mn |
| Sep 30, 2022 | -15.64 Mn |
| Jun 30, 2022 | -17.19 Mn |
| Mar 31, 2022 | -19.74 Mn |
| Dec 31, 2021 | -27.20 Mn |
| Sep 30, 2021 | -28.91 Mn |
| Jun 30, 2021 | -29.80 Mn |
| Mar 31, 2021 | -30.40 Mn |